[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
[ Tue, May 04th 2021 ]: WOPRAI
Kevin Heal Maintained (CBOE) at Strong Buy with Increased Target to $120 on, May 4th, 2021
- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Kevin Heal of Argus Research, Maintained "Cboe Global Markets, Inc." (CBOE) at Strong Buy with Increased Target from $110 to $120 on, May 4th, 2021.
Kevin has made no other calls on CBOE in the last 4 months.
There are 7 other peers that have a rating on CBOE. Out of the 7 peers that are also analyzing CBOE, 0 agree with Kevin's Rating of Hold.
These are the ratings of the 7 analyists that currently disagree with Kevin
- Brian Bedell of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $117 on, Monday, May 3rd, 2021
- Owen Lau of "Oppenheimer" Maintained at Buy with Increased Target to $120 on, Monday, May 3rd, 2021
- Sean Horgan of "Rosenblatt" Maintained at Strong Buy with Increased Target to $120 on, Monday, May 3rd, 2021
- Ben Herbert of "Citigroup" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, April 20th, 2021
- Richard Repetto of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $108 on, Thursday, March 4th, 2021
- Kenneth Hill of "Rosenblatt" Maintained at Strong Buy with Increased Target to $108 on, Monday, January 11th, 2021
- Kenneth Worthington of "JP Morgan" Downgraded from Hold to Sell on, Thursday, January 7th, 2021